Prediabetes Deserves More Attention: A Review
Open accessThe DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
Abstract
Evidence increasingly demonstrates that prediabetes is a toxic state, as well as a risk factor for diabetes, and is associated with pathophysiological changes in several tissues and organs. Unfortunately, use of available evidence-based treatments for prediabetes is low. This review seeks to explain why prediabetes must be viewed and treated as a serious pathological entity in its own right. It offers an overview of the pathophysiology and complications of prediabetes and describes how this condition can be reversed if all treatment avenues are deployed early in its course.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“not only because of the association between prediabetes and cardiovascular risk but also because of the opportunity to improve cardiovascular outcomes through appropriate weight management.”
From Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (2023) · cites this paper as [43]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Diabetes Prevention Program (DPP)
The Diabetes Prevention Program (DPP) Research Group (2002) · Diabetes Care · doi:10.2337/diacare.25.12.2165 · Cited by 1,938
Ramachandran, A., Snehalatha, C., Mary, S., Mukesh, B., Bhaskar, A. D., Vijay, V., & Indian Diabetes Prevention Programme (IDPP) (2006) · Diabetologia · doi:10.1007/s00125-005-0097-z · Cited by 1,881
Unwin, N. C. (2006) · Cited by 1,661
Huang, Y., Cai, X., Mai, W., Li, M., & Hu, Y. (2016) · BMJ · doi:10.1136/bmj.i5953 · Cited by 1,012 · cited 1×
“(26) concluded that IFG, IGT, and prediabetes (by the ADA A1C criterion) are independently associated with an increased risk of composite cardiovascular events, coronary heart disease, stroke, and all-cause mortality.”
BackgroundHuman Gut Microbiota Changes Reveal the Progression of Glucose Intolerance
Zhang, X., Shen, D., Fang, Z., Jie, Z., Qiu, X., Zhang, C., Chen, Y., & Ji, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071108 · Cited by 946
Definition, Classification and Diagnosis of Diabetes, Prediabetes and Metabolic Syndrome
Punthakee, Z., Goldenberg, R., & Katz, P. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.10.003 · Cited by 877
Definition, Classification and Diagnosis of Diabetes, Prediabetes and Metabolic Syndrome
Goldenberg, R., & Punthakee, Z. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.01.011 · Cited by 611
Aberrant intestinal microbiota in individuals with prediabetes
the IMI-DIRECT consortium, Allin, K. H., Tremaroli, V., Caesar, R., Jensen, B. A. H., Damgaard, M. T. F., Bahl, M. I., Licht, T. R., Hansen, T. H., Nielsen, T., et al. (2018) · Diabetologia · doi:10.1007/s00125-018-4550-1 · Cited by 460 · cited 2×
“(65) demonstrated intestinal dysbiosis characterized by depletion of the genus Clostridium and the mucin-degrading bacterium Akkermansia muciniphila.”
BackgroundResultDiabetes Prevention Program Research Group (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02043.x · Cited by 363
Prediabetes and Cardiovascular Disease
Brannick, B., & Dagogo-Jack, S. (2018) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2017.10.001 · Cited by 293 · cited 5×
“barriers, and increased ECM component interaction with cell surface receptors (5,7).”
BackgroundInfluentialOrtiz-Lopez, C., Lomonaco, R., Orsak, B., Finch, J., Chang, Z., Kochunov, V. G., Hardies, J., & Cusi, K. (2012) · Diabetes Care · doi:10.2337/dc11-1849 · Cited by 253 · cited 3×
“Nonalcoholic fatty liver disease (NAFLD) is a recognized disorder in people with prediabetes and diabetes alike (63,64).”
BackgroundSörensen, B. M., Houben, A. J. H. M., Berendschot, T. T. J. M., Schouten, J. S. A. G., Kroon, A. A., van der Kallen, C. J. H., Henry, R. M. A., Koster, A., Sep, S. J. S., Dagnelie, P. C., et al. (2016) · Circulation · doi:10.1161/circulationaha.116.023446 · Cited by 249
Epidemiology of polyneuropathy in diabetes and prediabetes
(2014) · Handbook of Clinical Neurology · doi:10.1016/b978-0-444-53480-4.00001-1 · Cited by 235
Prediabetes and the risk of cancer: a meta-analysis
Huang, Y., Cai, X., Qiu, M., Chen, P., Tang, H., Hu, Y., & Huang, Y. (2014) · Diabetologia · doi:10.1007/s00125-014-3361-2 · Cited by 234
Brannick, B., Wynn, A., & Dagogo-Jack, S. (2016) · Experimental Biology and Medicine · doi:10.1177/1535370216654227 · Cited by 177 · cited 10×
“Adipose tissue, especially that of visceral origin, also influences systemic endothelial function through secretion of inflammatory cytokines such as tumor necrosis factor-a, interleukin-6, leptin, and resistin (3,5,6).”
BackgroundInfluentialVistisen, D., Witte, D. R., Brunner, E. J., Kivimäki, M., Tabák, Á. G., Jørgensen, M. E., & Færch, K. (2018) · Diabetes Care · doi:10.2337/dc17-2530 · Cited by 174 · cited 1×
“(19) showed a high incidence rate of CVDanddeath among individualswith IFG, IGT, or and an A1C of 5.”
BackgroundLee, C. C., Perkins, B. A., Kayaniyil, S., Harris, S. B., Retnakaran, R. R., Gerstein, H. C., Zinman, B., & Hanley, A. J. (2015) · Diabetes Care · doi:10.2337/dc14-2585 · Cited by 173 · cited 1×
“(48) demonstrated that the prevalence of peripheral neuropathy was 29, 49, and 50% in people with normoglycemia, prediabetes, and new-onset diabetes, respectively, following adjustment for total cholesterol, LDL cholesterol, triglycerides, systolic blood pressure, central obesity, and smoking.”
BackgroundEchouffo‐Tcheugui, J. B., Narayan, K. M., Weisman, D., Golden, S. H., & Jaar, B. G. (2016) · Diabetic Medicine · doi:10.1111/dme.13113 · Cited by 150 · cited 1×
“(38) showed that prediabetes is modestly associated with an increased risk of CKD.”
BackgroundThe Vasculature in Prediabetes
Wasserman, D. H., Wang, T. J., & Brown, N. J. (2018) · Circulation Research · doi:10.1161/circresaha.118.311912 · Cited by 137 · cited 5×
“Advanced glycation end products activate various inflammatory pathways, including nuclear factor k B (4,6).”
BackgroundInfluentialKristian, R. E. T. T., & Gottwald‐Hostalek, U. (2019) · Current Medical Research and Opinion · doi:10.1080/03007995.2019.1601455 · Cited by 137 · cited 4×
“Prediabetes is defined as a state of abnormal glucose homeostasis in which blood glucose levels are elevated above those considered normal, but not high enough to meet the criteria required for a diagnosis of diabetes (1,2).”
BackgroundInfluentialWilson, R., Willis, J., Gearry, R., Skidmore, P., Fleming, E., Frampton, C., & Carr, A. (2017) · Nutrients · doi:10.3390/nu9090997 · Cited by 125
Zaccardi, F., Rocca, B., Pitocco, D., Tanese, L., Rizzi, A., & Ghirlanda, G. (2015) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2625 · Cited by 116 · cited 1×
“These abnormal platelet indices may cause increased platelet activation, contributing to CVD, amajor complication of prediabetes and diabetes (72).”
BackgroundPrediabetes: Why Should We Care?
Zand, A., Ibrahim, K., & Patham, B. (2018) · Methodist DeBakey Cardiovascular Journal · doi:10.14797/mdcj-14-4-289 · Cited by 113 · cited 5×
“Adipose tissue, especially that of visceral origin, also influences systemic endothelial function through secretion of inflammatory cytokines such as tumor necrosis factor-a, interleukin-6, leptin, and resistin (3,5,6).”
BackgroundInfluentialPrevention of Diabetes With Pioglitazone in ACT NOW
DeFronzo, R. A., Tripathy, D., Schwenke, D. C., Banerji, M., Bray, G. A., Buchanan, T. A., Clement, S. C., Gastaldelli, A., Henry, R. R., Kitabchi, A. E., et al. (2013) · Diabetes · doi:10.2337/db13-0265 · Cited by 109
Lundkvist, P., Sjöström, C. D., Amini, S., Pereira, M. J., Johnsson, E., & Eriksson, J. W. (2017) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12779 · Cited by 108
Bongaerts, B. W. C., Rathmann, W., Heier, M., Kowall, B., Herder, C., Stöckl, D., Meisinger, C., & Ziegler, D. (2013) · Diabetes Care · doi:10.2337/dc12-0744 · Cited by 106
Chiasson, J. L., Josse, R. G., Gomis, R., Hanefeld, M., Karasik, A., & Laakso, M. (2004) · Diabetologia · doi:10.1007/s00125-004-1409-4 · Cited by 104
Lee, G., Kim, S. M., Choi, S., Kim, K., Jeong, S., Son, J. S., Yun, J., & Park, S. M. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0694-z · Cited by 101
Ahn, C. H., Min, S. H., Lee, D.-H., Oh, T. J., Kim, K. M., Moon, J. H., Choi, S. H., Park, K. S., Jang, H. C., Ha, J., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-00191 · Cited by 91
Xu, J., Zhou, Q., Liu, G. C., Tan, Y., & Cai, L. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/635214 · Cited by 84
Xu, J., Xu, W., Yao, H., Sun, W., Zhou, Q., & Cai, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056750 · Cited by 84
Yi, S., Park, S., Lee, Y., Park, H.-J., Balkau, B., & Yi, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-08498-6 · Cited by 81
Association of Obstructive Sleep Apnea and Glucose Metabolism in Subjects With or Without Obesity
Kim, N. H., Cho, N. H., Yun, C., Lee, S. K., Yoon, D. W., Cho, H. J., Ahn, J. H., Seo, J. A., Kim, S. G., Choi, K. M., et al. (2013) · Diabetes Care · doi:10.2337/dc13-0375 · Cited by 79
Dietary reversal of neuropathy in a murine model of prediabetes and the metabolic syndrome
Hinder, L. M., O’Brien, P. D., Hayes, J. M., Backus, C., Solway, A. P., Sims‐Robinson, C., & Feldman, E. L. (2017) · Disease Models & Mechanisms · doi:10.1242/dmm.028530 · Cited by 75 · cited 1×
“Such intervention includes dietary modifications, exercise, avoidance of smoking and alcohol, and other measures (78).”
BackgroundEndoplasmic reticulum stress contributes to prediabetic peripheral neuropathy
Lupachyk, S., Watcho, P., Obrosov, A. A., Stavniichuk, R., & Obrosova, I. G. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.11.001 · Cited by 73
Fonville, S., Zandbergen, A. A. M., Koudstaal, P. J., & den Hertog, H. M. (2014) · Cerebrovascular Diseases · doi:10.1159/000360810 · Cited by 70
Risk factors for autonomic and somatic nerve dysfunction in different stages of glucose tolerance
Dimova, R. B., Tankova, T. I., Guergueltcheva, V., Tournev, I., Chakarova, N. Y., Grozeva, G. G., & Dakovska, L. N. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.11.002 · Cited by 67
Kowall, B., Lehnich, A., Strucksberg, K.-H., Führer, D., Erbel, R., Jankovic, N., Moebus, S., Jöckel, K., & Stang, A. (2016) · Sleep Medicine · doi:10.1016/j.sleep.2015.12.017 · Cited by 64 · cited 1×
“(54) showed an association between prediabetes or diabetes and sleep disturbances, irregular nocturnal sleep duration, and poor daytime napping.”
BackgroundDutta, D., Choudhuri, S., Mondal, S. A., Mukherjee, S., & Chowdhury, S. (2013) · Journal of Diabetes · doi:10.1111/1753-0407.12112 · Cited by 59
Long-term effect of rosiglitazone and/or ramipril on the incidence of diabetes
DREAM On (Diabetes Reduction Assessment with Ramipril and Rosiglitazone Medication Ongoing Follow-up) Investigators (2011) · Diabetologia · doi:10.1007/s00125-010-1985-4 · Cited by 54
Zaleska-Żmijewska, A., Piątkiewicz, P., Śmigielska, B., Sokołowska-Oracz, A., Wawrzyniak, Z. M., Romaniuk, D., Szaflik, J., & Szaflik, J. P. (2017) · Journal of Diabetes Research · doi:10.1155/2017/4174292 · Cited by 50
Kim, G. S., Oh, H. H., Kim, S., Kim, B. O., & Byun, Y. S. (2019) · BMC Nephrology · doi:10.1186/s12882-019-1307-0 · Cited by 49
Cefalu, W. T. (2016) · Diabetes Care · doi:10.2337/dc16-1143 · Cited by 48
Tsuda, A., Ishimura, E., Uedono, H., Ochi, A., Nakatani, S., Morioka, T., Mori, K., Uchida, J., Emoto, M., Nakatani, T., et al. (2018) · Diabetes Care · doi:10.2337/dc18-0718 · Cited by 46
Prediabetes and risk of diabetes and associated complications
Abdul‐Ghani, M. A., DeFronzo, R. A., & Jayyousi, A. (2016) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000307 · Cited by 45 · cited 1×
“(9,10), the authors seek to convince practitioners that prediabetes deserves more attention than it is presently being given.”
BackgroundMijajlovic, M. D., Aleksić, V., Šternić, N., Mirkovic, M., & Bornstein, N. M. (2017) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s128807 · Cited by 45 · cited 1×
“Additionally, Mijajlović et al. (17) and Fonville et al. (18) reported after performingmultivariate analysis that prediabetes may play an independent role in the causation of stroke.”
BackgroundTreating prediabetes: why and how should we do it?
Braga, T. G., Kraemer‐Aguiar, L. G., Docherty, N. G., & le Roux, C. W. (2019) · Minerva Medica · doi:10.23736/s0026-4806.18.05897-4 · Cited by 45 · cited 2×
“Bariatric surgery is another efficacious means of treating prediabetes and type 2 diabetes (9).”
BackgroundHung, H., Yang, Y., Ou, H., Wu, J., Lu, F., & Chang, C. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04423.x · Cited by 42
Metabolic syndrome, glucose tolerance categories and the cardiovascular risk in Spanish population
Martínez-Larrad, M. T., Anchuelo, A. C., Fernández, C., Redondo, Y. L., Escobar‐Jiménez, F., & Serrano‐Ríos, M. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.02.003 · Cited by 42
Increased Frequency of Prediabetes in Patients With Irritable Bowel Syndrome
Gülcan, E., Taşer, F., Toker, A., Korkmaz, U., & Alçelik, A. (2009) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e31819f7587 · Cited by 41 · cited 1×
“(67)? Future research should provide the answer to this question.”
BackgroundCorrelation Between Prediabetes Conditions and Microalbuminuria
Bahar, A., Makhlough, A., Yousefi, A., Kashi, Z., & Abediankenari, S. (2013) · Nephro-Urology Monthly · doi:10.5812/numonthly.7646 · Cited by 41
Rospleszcz, S., Schafnitzel, A., Köenig, W., Lorbeer, R., Auweter, S., Huth, C., Rathmann, W., Heier, M., Linkohr, B., Meisinger, C., et al. (2018) · BMC Cardiovascular Disorders · doi:10.1186/s12872-018-0900-7 · Cited by 40
Role of the Oral Glucose Tolerance Test (OGTT) in the idiopathic restless legs syndrome
Bosco, D., Plastino, M., Fava, A., Ettore, M., Bosco, F., Ermio, C., Tallarigo, F., Pirritano, D., & Consoli, D. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.09.008 · Cited by 32 · cited 1×
“(57,58) to occur more frequently among people with IGT.”
BackgroundVelija-Ašimi, Z., Bureković, A., Dujić, T., Dizdarević-Bostandžić, A., & Semiz, S. (2016) · Biomolecules and Biomedicine · doi:10.17305/bjbms.2016.1428 · Cited by 32
Giráldez‐García, C., Sangrós, F. J., Díaz-Redondo, A., Franch‐Nadal, J., Serrano, R., Díez, J., Buil‐Cosiales, P., Soidán, F. J. G., Artola, S., Ezkurra, P., et al. (2015) · Medicine · doi:10.1097/md.0000000000001935 · Cited by 30
Complications of dysglycemia and medical costs associated with nondiabetic hyperglycemia.
Nichols, G. A., Arondekar, B. V., & Herman, W. H. (2008) · PubMed · Cited by 29
Gagnon, C., Magliano, D. J., Ebeling, P. R., Dunstan, D. W., Zimmet, P., Shaw, J. E., & Daly, R. M. (2010) · Osteoporosis International · doi:10.1007/s00198-009-1164-y · Cited by 29
Hossain, I. A., Akter, S., Bhuiyan, F. R., Shah, M. R., Rahman, M. K., & Ali, L. (2016) · BMC Research Notes · doi:10.1186/s13104-016-2071-x · Cited by 26 · cited 2×
“Nonalcoholic fatty liver disease (NAFLD) is a recognized disorder in people with prediabetes and diabetes alike (63,64).”
BackgroundBosco, D., Costa, R., Plastino, M., Branca, D., Cotronei, P., Sperlì, T., Santacroce, N., Siniscalchi, A., Consoli, D., Ceccotti, C., et al. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.03.017 · Cited by 24
Zhao, Y., Sun, H., Wang, B., Zhang, M., Luo, X., Ren, Y., Zhou, J., Han, C., Wang, C., Li, L., et al. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.04.006 · Cited by 24
Ramírez, G. R., Simental‐Mendía, L. E., Carrera-Gracia, M., & Escorza, M. A. Q. (2017) · Archives of Medical Research · doi:10.1016/j.arcmed.2017.03.018 · Cited by 24
Silent myocardial ischemia in prediabetics in relation to insulin resistance
Nasr, G. M., & Sliem, H. A. (2010) · Journal of Cardiovascular Disease Research · doi:10.4103/0975-3583.70903 · Cited by 21
Yubero‐Serrano, E. M., Delgado‐Lista, J., Alcala-Diaz, J. F., García‐Ríos, A., Pérez-Caballero, A. I., Blanco-Rojo, R., Gómez-Delgado, F., Marín, C., Tinahones, F. J., Caballero‐Villarraso, J., et al. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.07.903 · Cited by 20
Güdül, N. E., Karabağ, T., Sayın, M. R., Bayraktaroğlu, T., & Aydın, M. (2016) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2014.380 · Cited by 20 · cited 1×
“(23) reported that atrial conduction times and P wave dispersion on surface electrocardiography were longer in people with prediabetes before the development of overt diabetes.”
BackgroundHadaegh, F., Ehteshami‐Afshar, S., Hajebrahimi, M. A., Hajsheikholeslami, F., & Azizi, F. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.01.017 · Cited by 19 · cited 1×
“(14) also demonstrated the association between prediabetes and CVD after controlling for other components of the metabolic syndrome, including systemic hypertension, dyslipidemia, and homeostasis model assessment of insulin resistance (HOMA-IR).”
BackgroundSimilä, T., AUVINEN, J. P., Puukka, K. S., Keinanen-Kiukaanniemi, S. M., & Virtanen, J. I. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.05.035 · Cited by 19 · cited 1×
“(70) reported that tooth loss was strongly associated with prediabetes and diabetes in middle-aged Finnish women after adjusting for insulin resistance indices, obesity indices, and other confounders.”
Backgroundde Almeida-Pititto, B., Ribeiro‐Filho, F. F., Lotufo, P. A., Benseñor, I. M., & Ferreira, S. R. G. (2015) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.04.021 · Cited by 17
Laparoscopic adjustable gastric banding and progression from impaired fasting glucose to diabetes
Wentworth, J. M., Hensman, T., Playfair, J., Laurie, C., Ritchie, M. E., Brown, W. A., Skinner, S., Shaw, J. E., & O’Brien, P. E. (2014) · Diabetologia · doi:10.1007/s00125-013-3129-0 · Cited by 16
Balcıoğlu, A. S., Akıncı, S., Çiçek, D., Çoner, A., Bal, U. A., & Müderrisoğlu, İ. H. (2016) · The Anatolian Journal of Cardiology · doi:10.14744/anatoljcardiol.2015.6654 · Cited by 16
Association of prediabetes-associated single nucleotide polymorphisms with microalbuminuria
Choi, J. W., Moon, S., Jang, E. J., Lee, C. H., & Park, J.-S. (2017) · PLoS ONE · doi:10.1371/journal.pone.0171367 · Cited by 16
Impact of prediabetes on poststroke depression in Chinese patients with acute ischemic stroke
Xiao, M., Wang, Q., Ren, W., Zhang, Z., Wu, X., Wang, Z., Feng, L., Chen, S., & He, J. (2018) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4878 · Cited by 15
Role of Impaired Glucose Metabolism in the Postherpetic Neuralgia
Bosco, D., Plastino, M., Bartolo, M. D., Cristiano, D., Ettore, M., Zurlo, G., Bosco, F., Colica, C., Tallarigo, F., & Fava, A. (2013) · Clinical Journal of Pain · doi:10.1097/ajp.0b013e318274b2ed · Cited by 12 · cited 1×
“(57,58) to occur more frequently among people with IGT.”
BackgroundWang, H., Yan, W., Dou, J., Lü, Z., Wang, B., & Mu, Y. (2017) · Chinese Medical Journal · doi:10.4103/0366-6999.202741 · Cited by 12
The role of increased glucose on neurovascular dysfunction in patients with the metabolic syndrome
Rodrigues, S., Cepeda, F. X., Toschi‐Dias, E., Dutra‐Marques, A. C. B., Carvalho, J. C., Costa‐Hong, V., Alves, M. J. N. N., Rondon, M. U. P. B., Bortolotto, L. A., & Trombetta, I. C. (2017) · Journal of Clinical Hypertension · doi:10.1111/jch.13060 · Cited by 12 · cited 1×
“(49) in a prospective study after adjusting for age, BMI, waist circumference, systolic blood pressure, diastolic blood pressure, HOMA-IR, triglycerides, HDL cholesterol, and apnea-hypopnea index.”
BackgroundAndersson, S., Ekman, I., Friberg, F., Bøg‐Hansen, E., & Lindblad, U. (2013) · BMC Public Health · doi:10.1186/1471-2458-13-700 · Cited by 11
Krysiak, R. G., Drosdzol-Cop, A. B., Skrzypulec‐Plinta, V., & Okopień, B. (2018) · Endokrynologia Polska · doi:10.5603/ep.2018.0021 · Cited by 11
[Factors associated with low ankle-brachial index in patients with type 2 diabetes and prediabetes].
Polenova, N., Явелов, И. С., & Gratsianskiĭ, N. A. (2009) · PubMed · Cited by 9
Sexual functioning and depressive symptoms in men with various types of prediabetes: a pilot study
Krysiak, R. G., Szkróbka, W., & Okopień, B. (2018) · International Journal of Impotence Research · doi:10.1038/s41443-018-0050-6 · Cited by 9
Prevalence of ocular abnormalities in prediabetic patients.
Sokołowska-Oracz, A., Litwińczuk-Hajduk, J., & Piątkiewicz, P. (2016) · PubMed · Cited by 8
Cervar-Zivkovic, M., Tönjes, A., Baber, R., Wirkner, K., Loeffler, M., & Engel, C. (2018) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.30 · Cited by 7 · cited 1×
“(37) demonstrated increased glomerular hydrostatic pressure and albuminuria in people with IFG, IGT, and/or prediabetes by the ADAA1C criterion even after adjusting for age, sex, obesity, hypertension, metabolic syndrome, and other risk factors for chronic kidney disease (CKD).”
BackgroundFlorid diabetic complications in impaired glucose tolerance
Gupta, A., Vibha, D., Sharma, A., Mahajan, S., & Bhatt, A. (2013) · Saudi Journal of Kidney Diseases and Transplantation · doi:10.4103/1319-2442.106251 · Cited by 6 · cited 1×
“(39) demonstrated proteinuria and nodular glomerulosclerosis in a middle-aged man with IGT.”
BackgroundAkhavan‐Khaleghi, N. (2018) · The Anatolian Journal of Cardiology · doi:10.14744/anatoljcardiol.2017.7957 · Cited by 6
Jończyk-Skórka, K., & Kowalski, J. (2017) · PubMed · Cited by 6
Ezerarslan, H., Çandar, T., Özdemir, S., Ataç, G. K., & Kocatürk, S. (2016) · Medical Principles and Practice · doi:10.1159/000446478 · Cited by 5 · cited 1×
“(59) detected sensorineural hearing loss in people with IFG.”
BackgroundLiu, Z., Wu, K., Dai, X., Che, Q., Chen, S., Jia, J., Li, J., Huo, Y., Zhang, Y., & Chen, D. (2017) · Journal of Diabetes Investigation · doi:10.1111/jdi.12741 · Cited by 5 · cited 1×
“(21) recently demonstrated that IFG, IGT, combined glucose intolerance (IFG plus IGT), and newly diagnosed diabetes were all related to a high risk of arterial stiffness in a Chinese community after adjusting for BMI, waist-to-hip ratio, smoking, alcohol intake, systolic blood pressure, diastolic blood pressure, serum…”
Background[Prevalence of erectile dysfunction in men with pre-diabetes: An investigation in Lanzhou].
Chen, H., Yang, Z., Yang, N., Zhang, J., Wang, J., Zhang, X., Han, Y.-M., & Yu, X.-N. (2017) · PubMed · Cited by 5
Rosiglitazone plus metformin to prevent type 2 diabetes mellitus
Ferrante, G., Zavalloni, D., Corrada, E., & Presbitero, P. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61948-4 · Cited by 3
Hung, H., Yang, Y., Ou, H., Wu, J., Lu, F., & Chang, C. (2012) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2012.04.010 · Cited by 3
Cited by
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
Lincoff, A. M., Brown-Frandsen, K., Colhoun, H. M., Deanfield, J., Emerson, S. S., Esbjerg, S., Hardt-Lindberg, S., Hovingh, G. K., Kahn, S. E., Kushner, R. F., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2307563 · Cited by 3,236
Yousef, H., Khandoker, A. H., Feng, S. F., Helf, C., & Jelinek, H. F. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1173402 · Cited by 76
Worldwide trends in prediabetes from 1985 to 2022: A bibliometric analysis using bibliometrix R-tool
Zhao, J., & Li, M. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1072521 · Cited by 69
Atherosclerosis and Insulin Resistance: Is There a Link Between Them?
Brie, A. D., Christodorescu, R., Popescu, R., Adam, O., Tîrziu, A., & Brie, D. M. (2025) · Biomedicines · doi:10.3390/biomedicines13061291 · Cited by 58
Cao, Z., Li, W., Wen, C. P., Li, S., Chen, C., Jia, Q., Li, W., Zhang, W., Tu, H., & Wu, X. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.4989 · Cited by 40
Metadata
- Authors
- Lawal, Y., Bello, F., & Kaoje, Y. S.
- Affiliations
- Federal Medical Centre (NG)
- Ahmadu Bello University Teaching Hospital (NG)
- Corresponding author
- Lawal, Yakubu
- ORCID
- Lawal, Yakubu
- Venue
- Clinical Diabetes
- Publisher
- American Diabetes Association
- Published
- 2020-10-01
- Volume
- 38
- Issue
- 4
- Pages
- 328-338
- ISSN
- 0891-8929 (ISSN-L)
- 1945-4953
- PMC
- PMC7566925
- OpenAlex
- W3026718593
- Cited by
- 61
- References
- 88
- Citations by year
- 2026: 13 · 2025: 19 · 2024: 17 · 2023: 7 · 2022: 5
- FWCI
- 2.26
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Clinical Diabetes (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- prediabetes, pathophysiology, diabetes risk, complications, treatment, early intervention, evidence-based treatment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.